PharmiWeb Today Story
World Tumor Registry has launched its Breast Cancer Registry, an open access digital platform designed to support more accurate breast cancer diagnosis worldwide. The new resource brings together expert reviewed tumour cases, including both common and rare forms, and allows users to study high quality whole slide images alongside clinical, biomarker and molecular information. Led by Dr Edi Brogi of Memorial Sloan Kettering Cancer Center, the project already includes 100 fully annotated cases, with a target of 500 by year end.
The organisation says the registry is intended to help pathologists and trainees around the world learn from a broader range of cases and improve diagnostic confidence. World Tumor Registry also plans to expand further with lung, skin and melanoma registries later this year, as part of a wider effort to build a comprehensive global educational cancer resource.
Read More...
Articles
Featured Events
-
PM Society: Measuring Patient Engagement: Opening…
12-Oct-2022 - 12-Oct-2022 -
Finding the Value in Strategic Outsourcing Partner…
22-Feb-2023 - 22-Feb-2023 -
Reuters Events: Pharma USA 2023
28-Mar-2023 - 29-Mar-2023 -
Pharmaceutical marketing for non-marketers
26-Sep-2023 - 28-Sep-2023 -
PharmaMarketing USA Summit
08-Feb-2024 - 09-Feb-2024 -
7th European Conference on Clinical Research: Push…
19-Feb-2024 - 20-Feb-2024
News
-
Instem Taps ex-Novartis Head of Emerging Technolog…
15-Apr-2026 -
New Method Enables Structural Determination of Div…
15-Apr-2026 -
Pangea Pharmaceuticals Announces U.S. Launch of Sd…
15-Apr-2026 -
Avant Brands Announces its Annual General and Spec…
15-Apr-2026 -
Enodia Therapeutics Appoints Dr. Yvonne McGrath as…
15-Apr-2026 -
Nucleai and Sirona Dx Partner to Deliver an Integr…
15-Apr-2026